Korean Drug Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Hai Park
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | 11.4% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Unpleasant Surprises Could Be In Store For Korean Drug Co., Ltd.'s (KOSDAQ:014570) Shares
Jun 19Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?
Mar 11Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?
Feb 19Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?
Jan 11Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?
Dec 24Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today
Dec 06Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 18CEO
Hai Park (89 yo)
no data
Tenure
Mr. Hai Ryong Park serves as Chairman, Chief Executive Officer and President of Korean Drug Co. Ltd. Mr. Park served as the Co-Chief Executive Officer of Korean Drug Co. Ltd., and also served as its Presid...